You searched for "impairment"

1995 results found

There will be a 27% rise in the number of people living with sight loss in the UK by 2035, RNIB the UK’s leading sight loss charity predicts

This World Sight Day, leading sight loss charity the Royal National Institute of Blind People (RNIB) was calling for the UK Government to prioritise eye health. This is after fresh insight from the charity that shows there will be a...

Moorfields Eye Charity appoints Louise Robertshaw as trustee

Louise Robertshaw has been appointed as a trustee at Moorfields Eye Charity. She will also chair the charity’s fundraising and communications committee. Louise has considerable experience working at a senior level and as a trustee at national charities including in...

Specialty-driven EMR for paperless clinical environment – insights for an informed choice

Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...

Michael Burdon to begin term of office as a BCPB Trustee

Michael Burdon begins his term of office as a BCPB Trustee in July 2020, and in October 2020 will become Chairman of the Council when Paul Hunter retires after six years.

British Council for Prevention of Blindness has a new Chairman

BCPB’s new Chairman Mr Michael Burdon FRCOphth FRCP is a consultant ophthalmologist at Queen Elizabeth Hospital Birmingham with a specialist interest in neuro-ophthalmology.

Treatment of diabetic macular oedema

Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...

Strategies for fostering psychological safety in healthcare

Holding a degree in Ecology, an MBA, and currently pursuing a Masters in Global Health and Humanitarianism at the University of Manchester, Tom merges academic knowledge with real-world experience. His focus lies in leveraging the transformative power of psychological safety,...

DR-NET National DR Workshop in Tanzania: Policy, training and technology

Diabetic retinopathy (DR) is a leading cause of moderate to severe visual impairment (VI) and blindness worldwide, posing a significant public health challenge. As the prevalence of diabetes continues to rise globally, particularly in low- and middle-income countries (LMICs), the...

Tackling diabetic retinopathy globally through the VISION 2020 LINKS Diabetic Retinopathy Network

It is abundantly clear that the burden of diabetes is rapidly increasing, as there are now 415 million adults with diabetes in the world, with a projected rise to 642 million by 2040 [1]. This equates to 1 in 10...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Changing the post cataract surgery review pathway – is patient safety compromised?

Cataract surgery continues to be the most commonly performed elective surgical procedure in the UK, with an annual rate of approximately 4150/100,000 people over the age of 65 accounting for a significant proportion of the surgical workload of most ophthalmologists...

Brain tumours in adults: the essentials for an ophthalmologist

The author provides a review of the common intracranial tumours in adults (other than pituitaries) which may present to an ophthalmologist. Primary malignant brain tumours comprise 3% of adult cancers but with an ageing population such tumours are becoming more...